Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B

被引:8
|
作者
Saito, T
Shinzawa, H
Uchida, T
Kawamata, O
Honma, S
Watanabe, H
Shao, L
Saito, K
Togashi, H
Takahashi, T
机构
[1] Yamagata Univ, Sch Med, Dept Internal Med, Yamagata 9909585, Japan
[2] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] SRL Inc, Ctr Mol Biol & Cytogenet, Hepatitis Virus Anal Sect, Tokyo, Japan
关键词
silent B; HBV mutant; X gene; PCR; quantitation;
D O I
10.1002/(SICI)1096-9071(199908)58:4<325::AID-JMV2>3.0.CO;2-L
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Low-level viremia due to hepatitis B virus (HBV) was demonstrated in the sera of two patients diagnosed previously as having non-B, non-C chronic hepatitis. Both patients had a "silent" HBV infection, because they were negative for both hepatitis:B surface antigen (HBsAg) and anti-hepatitis B core antibody. The TaqMan chemistry polymerase chain reaction (PCR) amplified the HBV DNA, enabling quantitation of the virus in their sera. Their serum HBV DNA concentrations were low: the amount of each HBV S or X gene amplified showed there were approximately 10(3) copies/ml and HBV DNA was detected occasionally during clinical follow-up. Positive HBsAg staining in liver tissues was demonstrated by an immunoperoxidase technique. Vertical transmission of silent HBV from one patient to her daughter was confirmed. Direct nucleotide sequencing of the amplified HBV X region revealed several mutations, suggesting reduced viral replication. One patient had a T-to-C mutation at the extreme 5'-terminus of the direct repeat 2 region and the other exhibited a coexisting X region with a 155-nucleotide deletion. These findings suggest that HBV replication is suppressed considerably in patients with silent hepatitis B. J. Med. Virol. 58: 325-331 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [31] Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease
    Zhang, Qian
    Peng, Hong
    Liu, Xiaoqing
    Wang, Huimin
    Du, Jinjie
    Luo, Xinhua
    Ren, Hong
    Hu, Peng
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 850 - 859
  • [32] Correlation between hepatitis B virus genotype and HBV DNA level in chronic hepatitis B patients
    Mahtab, M. A.
    Khan, M.
    Rahman, S.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S102 - S103
  • [33] Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B
    Wang, Jian
    Zhang, Zhiyi
    Zhu, Li
    Zhang, Qing
    Zhang, Shaoqiu
    Pan, Yifan
    Liu, Jiacheng
    Cao, Fei
    Fan, Tao
    Xiong, Ye
    Yin, Shengxia
    Yan, Xiaomin
    Chen, Yuxin
    Zhu, Chuanwu
    Li, Jie
    Liu, Xingxiang
    Wu, Chao
    Huang, Rui
    VIRULENCE, 2024, 15 (01)
  • [34] Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
    Ahn, Jem Ma
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2015, 62 : 986A - 986A
  • [35] Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
    Ahn, Jem Ma
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    PLOS ONE, 2015, 10 (12):
  • [36] Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B
    Feld, Jordan J.
    Ayers, Melissa
    El-Ashry, Dahlia
    Mazzulli, Tony
    Tellier, Raymond
    Heathcote, E. Jenny
    HEPATOLOGY, 2007, 46 (04) : 1057 - 1070
  • [37] Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemia
    Li, Zhong-Bin
    Li, Le
    Niu, Xiao-Xia
    Chen, Song-Hai
    Fu, Yi-Ming
    Wang, Chun-Yan
    Liu, Yan
    Shao, Qing
    Chen, Guofeng
    Ji, Dong
    LIVER INTERNATIONAL, 2021, 41 (06) : 1254 - 1264
  • [38] Quantitative Hepatitis B surface Antigen level as a indicator for cessation of antriviral therapy in patients with chronic hepatitis B
    Park, Yun Gyoung
    Paik, Yong Han
    Min, Yang Won
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    HEPATOLOGY, 2012, 56 : 364A - 364A
  • [39] Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
    Gauthier, J
    Bourne, EJ
    Lutz, MW
    Crowther, LM
    Dienstag, JL
    Brown, NA
    Condreay, LD
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06): : 1757 - 1762
  • [40] Paired measurements of quantitative hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients
    van der Eijk, AA
    Niesters, HGM
    Hansen, BE
    Pas, SD
    Janssen, HLA
    Schalm, SW
    de Man, RA
    JOURNAL OF HEPATOLOGY, 2004, 40 : 126 - 126